• SENSEX 82,530.74
    1,200.18 (+1.48%)
  • BANKNIFTY 55,355.60
    554.30 (+1.01%)
  • Cochin Shipyard
    1,831.00 2,977.10(%)
  • One 97
    863.90 1,063.00(%)
  • Mazagon Dock
    3,217.65 3,229.00(%)
  • Garden Reach Sh.
    2,340.00 2,834.60(%)
  • Tata Motors
    729.95 1,179.05(%)
  • Hind.Aeronautics
    4,883.00 5,675.00(%)
  • OneSource Speci.
    1,567.95 1,163.05(%)
  • Bharat Electron
    351.00 351.00(%)
  • Suzlon Energy
    61.77 86.04(%)
  • St Bk of India
    809.50 912.10(%)
  • Yes Bank
    21.70 27.41(%)
  • Reliance Industr
    1,461.00 1,608.95(%)
  • Vodafone Idea
    7.27 19.15(%)
  • Bharti Airtel
    1,869.65 1,916.90(%)
  • Tata Power Co.
    404.55 494.85(%)
  • Swiggy
    318.00 617.00(%)
  • Infosys
    1,618.85 2,006.80(%)
  • Dixon Technolog.
    16,520.00 19,149.80(%)
  • Jio Financial
    274.40 376.00(%)
  • ITC
    435.40 500.01(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mankind Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 38451.0
  • ISIN : INE634S01028
2,559.90 5 (0.21%)
  • As on 16 May 2025 (EOD)

  • Today’s Low

    2,516.00

  • Today’s High

    2,573.10

  • Open

    2,553.80

  • Perv Close

    2,554.60

  • 52W Low

    1,901.05

  • 52W High

    3,054.80

Key Indicators

  • P/E(TTM)

    54.63

  • Mar.Cap (₹Cr.)

    105,615.98

  • Div & Yield %

    0.00

  • Book Value(₹)

    334.17

  • Debt-Equity Ratio

    0.21

  • AGM Date

    15-May-2025

  • EPS

    46.87

  • P/E Ratio

    54.63

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    105,615.98

  • RONW (%)

    23.12

  • ROCE (%)

    27.91

Score Board

  • Equity (₹ in Cr.)

    41.26

  • BV (₹)

    334.20

  • Sales( ₹ in Cr.)

    9,264.81

  • NP (in Cr.)

    1,715.30

  • NP Var(%)

    41.0

  • Div%

    0.0

  • CPS (₹)

    49.30

  • EPS (₹)

    41.60

  • Traded Value (₹ in Lakhs)

    105,632.48

  • 52 Week High

    3,054.80

  • 52 Week Low

    1,901.05

  • Price BSE

    2560.0

  • Price NSE

    2,560.00

  • Market Capital( in Cr.)

    105,632.48

  • P/C Ratio

    52.00

  • P/E Ratio

    61.60

  • Price Vs.BV

    41.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 9,264.81 8,127.15 7,486.22 5,523.18 4,794.41 3,829.06
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 9,264.81 8,127.15 7,486.22 5,523.18 4,794.41 3,829.06
Other Income 266.64 162.78 203.81 154.50 93.85 64.33
Stock Adjustments 25.36 -267.89 365.27 254.25 44.51 -22.08
Total Income 9,556.81 8,022.04 8,055.30 5,931.93 4,932.77 3,871.31
EXPENDITURE :            
Raw Materials 2,933.66 2,576.87 2,886.71 2,036.42 1,617.42 1,370.37
Power and Fuel Cost 70.43 62.00 60.36 47.16 46.49 35.07
Employee Cost 1,982.10 1,701.38 1,462.76 1,167.42 991.47 785.02
Other Manufacturing Expenses 143.14 113.62 93.57 56.71 57.73 84.26
Selling and Administration Expenses 1,699.55 1,539.07 1,378.52 905.53 696.80 750.99
Miscellaneous Expenses 135.67 168.47 131.08 192.07 185.06 76.31
Employee Benefit Expenses 1,982.10 1,701.38 1,462.76 1,167.42 991.47 785.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6,964.55 6,161.40 6,013.00 4,405.31 3,594.98 3,102.02
Operating Profit 2,592.25 1,860.65 2,042.30 1,526.62 1,337.79 769.30
Interest 15.08 28.23 47.54 8.23 11.10 39.61
Gross Profit 2,577.17 1,832.42 1,994.76 1,518.39 1,326.69 729.69
Depreciation 317.61 269.58 123.33 78.19 61.77 38.39
Profit Before Tax 2,259.56 1,562.84 1,871.43 1,440.20 1,264.92 691.30
Current Tax 416.56 291.64 429.03 346.99 341.81 187.46
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 19.60 22.94 52.98 8.84 -35.11 -10.20
Reported Net Profit 1,823.41 1,248.26 1,389.42 1,084.37 958.23 514.04
Extraordinary Items 108.11 29.02 62.07 30.09 18.58 -0.23
Adjusted Net Profit 1,715.30 1,219.24 1,327.35 1,054.28 939.65 514.27
Adjustment below Net Profit -6.70 -4.86 -0.79 -1.56 -69.15 -1.64
P & L Balance brought forward 7,868.30 6,624.90 5,236.27 3,747.13 3,160.50 2,677.03
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 302.44 28.93
P & L Balance carried down 9,685.02 7,868.30 6,624.90 4,829.95 3,747.13 3,160.50
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 755.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 7.55 0.00
Earnings Per Share-Unit Curr 45.52 31.16 34.68 27.07 23.92 12.83
Earnings Per Share(Adj)-Unit Curr 45.52 - - - - -
Book Value 240.24 194.31 163.27 118.18 91.15 76.51
Book Value(Adj)-Unit Curr 240.24 - - - - -

Shareholding Pattern

  • Promoter Group

    72.70%

  • Public Share Holding

    27.30%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 74,921,805 18.16 74,921,805 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 225,038,807 54.54 225,038,807 3
Others 0 0.00 0 0
Sub Total 299,960,612 72.70 299,960,612 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 3,013 0.00 3,013 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 53,294,576 12.92 53,294,576 554
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 9,201,958 2.23 9,201,958 11
Mutual Funds / UTI 31,642,919 7.67 31,642,919 32
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,509,731 1.58 6,509,731 42
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 100,652,197 24.40 100,652,197 640
2] Non Institution
Bodies Corporate 4,580,019 1.11 4,580,019 768
Clearing Members 217 0.00 217 4
Directors of their Relatives 0 0.00 0 0
Employees 61,646 0.01 61,646 10
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 298,542 0.07 298,542 2,910
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 237,397 0.06 237,397 3,607
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 6,774,392 1.64 6,774,392 172,636
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,365 0.00 5,365 8
Others 8,140 0.00 8,140 1
Sub Total 11,965,718 2.90 11,965,718 179,944
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 412,578,527 100.00 412,578,527 180,597

Company Background

Mankind Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Mankind Pharma Ltd
  • BSE Code : 38451.0
  • ISIN : INE634S01028

  • Incorporation Year

    1991

  • Registered Office

    208 Okhla Industrial Estate
    Phase-III, New Delhi,
    New Delhi-110020

  • Telephone

    91-11-47476600

  • FAX

  • Chairman

    RAMESH CHAND JUNEJA

  • Managing Director

  • Company Secretary

    Hitesh Kumar Jain

  • Auditor

    S R Batliboi & Co LLP/Bhagi Bhardwaj Gaur & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Mankind Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mankind Pharma 2,560.30 9,531.45 9,264.81 52.34 25.77
Abbott India 30,371.20 6,097.18 5,848.91 48.36 44.71
Astrazeneca Phar 7,947.60 1,330.33 1,295.53 204.89 33.26
P & G Health Ltd 5,247.85 1,166.89 1,151.26 36.82 39.76
Glaxosmi. Pharma 2,878.70 3,530.73 3,407.25 53.06 44.44
Cipla 1,502.25 17,645.00 16,574.34 23.52 20.10
Amrutanjan Healt 717.35 437.58 421.23 42.05 20.84
Guj. Themis Bio. 325.45 174.19 169.82 67.38 44.82
Fermenta Biotec. 288.75 315.24 307.09 27.37 4.10
Bliss GVS Pharma 120.45 638.96 605.46 18.39 11.19
Ambalal Sarabhai 38.18 11.70 3.81 16.32 1.92